Prezent Boosts Board with Janet Dorling to Drive AI in Biopharma
Company - People | Apr 10, 2025 | WestWave Capital LLC
Prezent, an AI-powered platform designed for business presentations, has made a notable addition to its Board of Directors by appointing Janet Dorling, Senior Vice President at Gilead Sciences. Dorling, a seasoned leader with over 25 years of experience across startups and major enterprises, is expected to significantly contribute to Prezent's mission by leveraging her deep expertise in biotech and pharmaceuticals. This strategic move is seen as part of Prezent's efforts to address the costly issue of ineffective communication in business, as Dorling's appointment aligns with the company's overarching goal to fuel AI innovation within the biopharma industry. WestWave Capital LLC, a private equity firm, is the investor behind Prezent.
Sectors
- Biopharmaceuticals
- Artificial Intelligence
Geography
- United States – Prezent and Gilead Sciences are both based in the United States, making it a primary geography relevant to the article.
Industry
- Biopharmaceuticals – The appointment of Janet Dorling from Gilead Sciences highlights Prezent's focus on innovations within the biopharma industry.
- Artificial Intelligence – Prezent's platform leverages AI technology for business presentations, focusing on solving communication challenges.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Prezent | Target Company | Company | An enterprise-grade AI platform focused on enhancing business presentations. |
| WestWave Capital LLC | Investor | Company | A private equity firm that invests in innovative companies like Prezent. |
| Janet Dorling | Board of Directors Member | Person | Senior Vice President at Gilead Sciences with over 25 years of leadership experience in the biopharma industry. |
| Gilead Sciences | Dorling's Current Company | Company | A global biopharmaceutical company focused on innovative treatments. |